Call for Abstract

14th World Drug Delivery Summit, will be organized around the theme “Advancement in the Technologies used in Drug Delivery ”

Drug Delivery 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Drug Delivery 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Drug repurposing is a methodology for making more value from an existing drug by targeting diseases by focusing on infections other than that for which it was initially proposed, For instance, teicoplanin, oritavancin, dalbavancin and monensin are affirmed antibiotics that have been appeared to inhibit corona- and other viruses in the research facility. The researchers reviewed information on the discovery and development of wide-spectrum antiviral agents (BSAAs), which are drugs that target viruses from two or more different viral families. They condensed what they found for 120 drugs that had just been demonstrated to be ok for people use and made a database, which is uninhibitedly available Thirty-one of these were found by the researchers to be possible candidates for prophylaxis and treatment of the COVID-19 infections. The researchers also found that clinical investigations have recently begun of five possible drug candidates to treat the virus that causes COVID-19

  • Track 1-1 Carona Virus Drugs
  • Track 1-2 Coronavirus vaccine by Immuno Precise Antibodies
  • Track 1-3 Clinical Development of Drugs
  • Track 1-4 Targets for Antiviral Drugs

Advanced drug delivery systems (DDS) involves indubitable advantages for drug administration. Over the past three decades, new proposals have been recommended for the evolution of novel carriers for drug delivery. General concepts and emerging research in this field based on multidisciplinary proposals aimed at generate customized treatment for a broad range of highly universality diseases (e.g., cancer and diabetes). This review is made of two parts. The first part supply an overview on currently available drug delivery technologies counting a brief history on the development of these systems and some of the research strategies applied. The second part supply information about the most advanced drug delivery devices using stimuli-responsive polymers.




  • Track 2-1 Implantable Drug Delivery System
  • Track 2-2Pediatric Drug Delivery systems
  • Track 2-3Traditional Delivery Routes
  • Track 2-4Innovative Drug Delivery Technologies
  • Track 2-5Intramuscular (in a muscle)

Target drug delivery system is a marked form of drug delivery system. The therapeutic response of a drug based upon the interaction of drug molecules with cell on cell membrane interconnected biological events at receptor sites in concentration dependent manner. Targeted drug delivery entail for selective and functional localization of pharmacologically active moiety at pre recognized (preselected) target in therapeutic concentration, while moderate its entrance to non-target normal cellular linings, thus reduce toxic effects and increase therapeutic index. Targeting of drugs to marked cells and tissues of the body without their becoming a part of systemic circulation is a tremendous novel idea. If a drug can be distribute in a form such that it reaches the receptor sites in adequate concentration without interrupting in extraneous tissue cells.


  • Track 3-1Targeted Drug
  • Track 3-2Target Identification
  • Track 3-3Molecular Dynamics Simulations
  • Track 3-4Virtual Screening

Pharmaceutical drug delivery technologies magnify drug absorption, efficacy, and patient experience. Taste maskers increase the commercial viability of your pharmaceutical products by neutralizing the strong, bitter tastes of certain oral medical formulations. “A growing number of companies are investing in technologies counting  pen injectors , dry powder inhalers (DPIs),  auto injectors, nasal sprays, buccal films, intraocular implants, orally disintegrating tablets (ODT), and infusion pumps, numerous  of which are draft for use with biologic drugs. The evolutions in these areas are a result of their proven technology, high dose efficacy, and their capability to offer magnify patient comfort and compliance.”


  • Track 4-1Drug-Device compatibility
  • Track 4-2Sustained delivery
  • Track 4-3Pharmaceutical Nanotechnology

The development and optimization of drug delivery approaches based in nanoparticles concerns the early detection of cancer cells and/or specific tumour biomarkers, and the enhancement of the efficacy of the treatments applied. The usage of ideal nano-drug delivery system is obstinate principally depend on the biophysical and biochemical properties of the targeted drugs being adopt for the treatment. Thus, using green nanoparticles for drug delivery can reduce the side-effects of the medications. Moreover, naturalizations in nanostructures hydrophobicity, size, surface changes and shape, can further magnify the bioactivity of these nanomaterials.


  • Track 5-1Nanoparticles: Innovations And Trends
  • Track 5-2Nanomedicine And Biomedical Applications
  • Track 5-3Clinical Translation Of Nanotechnology
  • Track 5-4Clinical Translation Of Nanotechnology
  • Track 5-5Nanoparticles For Immuno-Oncology And Screening

Novel Drug delivery System (NDDS) developed in order to reduce drug degradation, drug adverse effect, and in order to maximize the drug bioavailability (amount of drug available at site targeted region).  Site specific drug delivery may be active or passive process. Novel Drug Delivery System is a fusion of advanced skills and advanced dosage forms which are far fitter than conventional dosage forms. Evolution of an existing drug molecule from a conventional form to a novel delivery system can importantly improve its presentation in terms of patient acquiescence, security and potency.  In the form of a Novel Drug Delivery System a live drug molecule can get a new life.


  • Track 6-1Liposomes
  • Track 6-2Hydrogels / Microgels
  • Track 6-3Drug loaded Erythrocytes/ Particles
  • Track 6-4Fast dissolving Tablets

Drug discovery is a versatile process by which new therapeutics are expanded. From initial target identification to late stage clinical trials, a wide range of scientific personnel are required from across the biosciences and beyond. Biologists, protein scientists, medicinal chemists, pharmacologists, toxicologists and computational scientists all have key roles to play. This process is essential as it is the means by which new drugs, frequently with novel modes of action, become accessible to patients.


  • Track 7-1Emergent Drug Development Approaches and Opportunities
  • Track 7-2Nucleic Acids as Drugs, Drug Targets and Gene Editing
  • Track 7-3Chemical approaches to Drug Discovery
  • Track 7-4Drug Efficacy and Toxicology

Targeted drug delivery to diseased tissues suggests keen benefits for therapy, such as enlarge potency and decrease side effects. The evolution of targeted drug delivery systems is handling by various drug design concerns, election of suitable cell culture models, and analytical tools for their observation. Targeting cells depend on the hardware encoding biological information. Whereas a practical benefit of the genetic code has not been announce until now, that of the peptide code constituted by antibody-based conceptions entered clinical trials and few products are already on the market. Recently, usage of the sugar code also became evident as a promising alternative.


  • Track 8-1Drug Targeting and Design
  • Track 8-2DNA Delivery System
  • Track 8-3Micelles
  • Track 8-4Liposomes

Most explored approaches to developing cell-based Anti Cancer drug delivery systems (DDSs) are encapsulation of the drug into the cells, cell surface modification, genetic modification of cells to secrete desired therapeutic proteins, and generating new biosynthetic systems. Tumor-tropism of mesenchymal stem cells (MSCs), as reveal in many studies, can be incorporate with expropriate engineering with anticancer genes to authorize their utilization in anticancer therapy. Furthermore, MSCs can be filled with nanoparticles (NPs), procure transport across the blood-brain barrier and accumulation of anticancer agent at the tumour site


  • Track 9-1Neural Drug Delivery
  • Track 9-2Anti-Cancer Drug Discovery and Development
  • Track 9-3Cancer Medicine- Bio Pharma Industry
  • Track 9-4Chemotherapy

Vaccines are determine as “preparations given to patients to induce immune reaction  dominant to the making of antibodies (humoral) or cell-mediated reaction that will help in attacking infectious agents or non-infectious state such as malignancies”. Sub-unit vaccines though exceptionally selective and specific in reacting with antibodies often fail to show such reactions in circumstances such as shifts in epitopic identification center of antibody and are poorly immunogenic. Active immunization is process of enlarge retardation to infection where by microorganism or product of their pursuit act as a antigens and restorate certain body cell produce a antibodies with particular defensive capacity.


  • Track 10-1Cancer Vaccines
  • Track 10-2Influenza Vaccines/Virus
  • Track 10-3Novel Vaccines
  • Track 10-4Human vaccines

Peptide and Protein drug delivery system are known as Novel drug Delivery System. Proteins and peptides are the most abundant components of biological cells. They exist functioning such as enzymes, hormones, structural element and immunoglobulin. The twenty various naturally transpire amino acids join with each other by peptide bonds and construct polymers mentioned to peptides and proteins. Although the variance between peptides and proteins are peptide having less than 20 amino acids, having a molecular weight less than 5000, while a protein contain 50 or more amino acids and its molecular weight lies high this value. Many of pharmaceutical proteins and peptides are engross IM, IV and Subcutaneous route of Absorption, but the oral route is more appropriate for absorption of protein as collate to other.


  • Track 11-1Oral Peptide Delivery
  • Track 11-2Polymer Carrier Systems
  • Track 11-3Enzyme Inhibitors
  • Track 11-4Absorption Enhancers

Therapeutic uses of a diverse of drug carrier systems have compelling effect on the treatment and possible heal of various chronic diseases, including Alzheimer, parkinsons, diabetes mellitus, cancer , psoriasis, , rheumatoid arthritis, HIV infection, infectious diseases, asthma, and drug addiction. Scientific attempts in these areas a versatile, including the biological, medical, physical, pharmaceutical, biological materials, and engineering fields. Drug carrier systems are now as important as the drug itself. Controlled release supply extends delivery of a drug while sustaining its blood concentration within therapeutic limits.


  • Track 12-1Polymers in Drug Delivery
  • Track 12-2Smart Materials For Drug Delivery
  • Track 12-3Drug Delivery Vehicles
  • Track 12-4Biomaterials in Drug Delivery

Advances in drug formulations and inventive routes of administration have been made. Our comprehension of drug transport across tissues has enlarged. These transformation have frequently caused in enhance patient constancy to the therapeutic regimen and pharmacologic response. The administration of drugs by transdermal or transmucosal routes provides the prevalence of being relatively painless. Also, the potential for immense compliance in a variety of clinical situations exists, frequently precluding the obligation to initiate intravenous access, which is a specific assistance for children. This report focuses on the advantages and disadvantages of alternative routes of drug administration. Concerns of specific significance in the protection of pediatric patients, particularly elements that could guide to drug-related toxicity or adverse responses, are emphasized.


  • Track 13-1Subcutaneous (under the skin)
  • Track 13-2Intravenous (in a vein)
  • Track 13-3Intrathecal (around the spinal cord)

Pharmaceutical formulations are combination of the pharmaceutically active ingredient and determine inactive ingredients. Solution formulations that are used for injectable dosage forms commonly have some inactive ingredients—such as buffering agents, water, co-solvents, and pH-adjusting agents. As a consequence, they are copious easy to formulate collate to some of the semisolid formulations used for topical administration. A pharmaceutical formulation is made of various formulation factors and process variables. Quantitative model-based pharmaceutical formulation includes initiating mathematical relations enclosed by the formulation variables and the emerge responses and extend the formulation cases.


  • Track 14-1Drug Formulation Procedures
  • Track 14-2Solid Dosage Forms
  • Track 14-3Semi-Solid Dosage Forms
  • Track 14-4Liquid Dosage Forms
  • Track 14-5Gaseous Dosage Forms

The brain is shielded and segregated from the normal circulation by a highly adequate blood-brain barrier. This is characterised by relatively impermeable endothelial cells with tight junctions, enzymatic activity and active efflux transport systems. Therefore the blood-brain barrier is layout to allow discriminatory carrier of molecules that are important for brain function. This builds a extensive protest for the treatment of central nervous system diseases compelling therapeutic levels of drug to get into the brain. Some small lipophilic drugs diffuse across the blood-brain barrier- sufficiently well to be efficacious. However, many potentially useful drugs are excluded.


  • Track 15-1Permeable Blood-Brain Barrier
  • Track 15-2Actively Targeted Delivery
  • Track 15-3Non-Invasive Techniques
  • Track 15-4Nanoparticles for Brain Imaging/Diagnostics

Controlled drug release and consequent ecological are important for evolving fortunate formulations. The method of delivery can be the variation enclosed by a drug’s accomplishment and failure, as the selection of a drug is frequently persuaded by the way the medicine is administered. Sustained (or continuous) release of a drug includes polymers that deliver the drug at a controlled rate due to dispersion out of the polymer or by degradation of the polymer over time. Pulsatile release is frequently the selected method of drug delivery, as it enclosure mimics the way by which the body generally produces hormones such as insulin. It is accomplished by using drug-carrying polymers that react to particular stimuli (e.g., exposure to light, changes in pH or temperature).


  • Track 16-1Bioavailability Enhancing Technologies
  • Track 16-2Extended Release Technologies
  • Track 16-3Capsule-in-Capsule Technology
  • Track 16-4Controlled Release process

Bio adhesive liposomes contain levonorgestrel as controlled drug delivery system has been investigated. Mesophasic proliposomal system for levonorgestral was processed. The vesicles were predominantly unilamellar and some were multilamellar. Deliver was of zero order kinetics. Alcohol as compared to oils had tremendous influence on transdermal flux. In vivo studies demonstrate that important lag phase was notice before the therapeutic levels were reached reveal the specification for a loading dose. This pro liposomes system was begin to be superior to PEG-based ointment system. Liposomal reservoir system containing local anaesthetic benzocaine was evolved for controlled and localized delivery via topical route. The liposomal suspension was included into an ointment and gel base.


  • Track 17-1Transdermal Vaccines
  • Track 17-2Biochemical enhancers
  • Track 17-3Electroporation
  • Track 17-4Micro Needles

Pharmaceutical biotechnology has been display therapeutic accomplishment never attain with standard drug molecules. Accordingly biopharmaceutical products are presently well-established in clinic and the evolution of new ones is anticipated. These products comprise mainly therapeutic proteins, although nucleic acids and cells are also included. However, as stated to their sensitive molecular structures, the systematic delivery of biopharmaceuticals is challenging. Various delivery systems (e.g. Micro particles and nanoparticles) made of several materials (e.g. polymers and lipids) have been analysed and determine tremendous outcomes, such as: high cellular transfection ability for nucleic acids, increased proteins, cell targeting, and peptides bioavailability, improved immune response in vaccination, and viability maintenance of microencapsulated cells, Drug implants.


  • Track 18-1Drug Implants
  • Track 18-2Biopharmaceutical Drugs
  • Track 18-3Novel Potential Therapeutics
  • Track 18-4Biomaterials

Medical devices layout for drug delivery through the pulmonary and nasal routes. These routes are of interest for local delivery, as in asthma, but also for rapid delivery of drugs to the system circulation and direct delivery to the central nervous system. Devices that report for particular anatomical and physiological features of the intranasal and pulmonary routes will be characterized. Drug delivery devices are specialized tools for the delivery of a drug or therapeutic agent via a particular route of administration. Such devices are used as bit of one or more medical treatments. Many in the industry have lengthy felt overly laden by what they acknowledge to be an unessential complicated approval process. Critics declare it impedes innovation and detain the opportunity of better health care. In order to help innovators import health care to the public.


  • Track 19-1Medical Devices for Drug Delivery
  • Track 19-2Biomedical Instrumentation Measurements
  • Track 19-3Quality by Design (QBD)
  • Track 19-4Ophthalmic and ENT Instruments